We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-8.81%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$369M
AUM Growth
-$22.3M
Cap. Flow
+$15.3M
Cap. Flow %
4.14%
Top 10 Hldgs %
67.81%
Holding
26
New
2
Increased
14
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$30.8M
2
JNJ icon
Johnson & Johnson
JNJ
+$12.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$10.7M
4
BIIB icon
Biogen
BIIB
+$9.44M
5
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$4.72M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$17.9M
2
SYK icon
Stryker
SYK
+$16.3M
3
TEVA icon
Teva Pharmaceuticals
TEVA
+$15.5M
4
MDCO
Medicines Co
MDCO
+$11.9M
5
THOR
THORATEC CORPORATION
THOR
+$10.2M

Sector Composition

Rank Sector Weight
1 Healthcare 87.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$609B
$39.2M 10.62%
420,100
+132,300
+46% +$12.8M
LLY icon
2
Eli Lilly
LLY
$1.05T
$30.6M 8.29%
365,947
-8,300
-2% -$701K
BSX icon
3
Boston Scientific
BSX
$65.4B
$28.4M 7.69%
1,731,900
-32,100
-2% -$549K
BXLT
4
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$28.1M 7.61%
+892,200
New +$30.8M
BAX icon
5
Baxter International
BAX
$11.7B
$27.6M 7.47%
839,400
-474,154
-36% -$17.9M
BMY icon
6
Bristol-Myers Squibb
BMY
$124B
$26.6M 7.19%
448,800
+169,400
+61% +$10.7M
IRWD icon
7
Ironwood Pharmaceuticals
IRWD
$635M
$19M 5.15%
2,180,472
+505,420
+30% +$4.72M
RVTY icon
8
Revvity
RVTY
$12.3B
$17.9M 4.86%
390,360
+35,300
+10% +$1.75M
CAH icon
9
Cardinal Health
CAH
$53.5B
$17.5M 4.74%
227,900
+18,500
+9% +$1.55M
BIO icon
10
Bio-Rad Laboratories Class A
BIO
$8.15B
$15.5M 4.19%
115,100
+9,700
+9% +$1.4M
IART icon
11
Integra LifeSciences
IART
$1.5B
$13M 3.52%
436,926
-25,611
-6% -$801K
CI icon
12
Cigna
CI
$74.5B
$11.7M 3.17%
86,600
+13,600
+19% +$1.97M
MASI
13
DELISTED
Masimo
MASI
$11.5M 3.11%
298,023
+25,400
+9% +$1.04M
VRTX icon
14
Vertex Pharmaceuticals
VRTX
$123B
$11.2M 3.02%
107,063
+33,600
+46% +$4.32M
THC icon
15
Tenet Healthcare
THC
$16.8B
$10.6M 2.86%
286,400
-6,600
-2% -$341K
ACH
16
Accendra Health
ACH
$266M
$10.2M 2.77%
320,752
+86,500
+37% +$2.94M
SYK icon
17
Stryker
SYK
$123B
$9.14M 2.47%
97,083
-164,400
-63% -$16.3M
BIIB icon
18
Biogen
BIIB
$30.4B
$8.35M 2.26%
+28,600
New +$9.44M
RAD
19
DELISTED
Rite Aid Corporation
RAD
$7.77M 2.1%
64,025
+10,885
+20% +$1.81M
CYH icon
20
Community Health Systems
CYH
$465M
$7.55M 2.04%
213,686
+20,207
+10% +$927K
WCG
21
DELISTED
Wellcare Health Plans, Inc.
WCG
$7.46M 2.02%
86,545
-11,900
-12% -$1.04M
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$5.76M 1.56%
350,920
+210,480
+150% +$4.31M
MDCO
23
DELISTED
Medicines Co
MDCO
$4.28M 1.16%
112,755
-337,995
-75% -$11.9M
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$447K 0.12%
74,700
+5,200
+7% +$36.1K
TEVA icon
25
Teva Pharmaceuticals
TEVA
$37.3B
– –
-262,000
Closed -$15.5M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q3 2015 Portfolio in Review

As of Q3 2015, Sector Gamma AS held 26 positions worth $369M, down 5.7% from $392M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Sector Gamma AS deployed $15.3M of net new capital in Q3 2015, opening 2 new positions and adding to 14 existing holdings. Its largest new stake was BAXALTA INC COM STK (DE): 892,200 shares worth $28.1M.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 90% a quarter earlier.

On the sell side, the largest reduction was Baxter International, an estimated $17.9M trimmed.

  • Sector Gamma AS's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 892,200 shares worth $28.1M.
  • Sector Gamma AS added most to Johnson & Johnson in Q3 2015, an estimated $12.8M increase.
  • Sector Gamma AS's biggest Q3 2015 reduction was Baxter International, cutting an estimated $17.9M.
  • Sector Gamma AS fully exited Teva Pharmaceuticals in Q3 2015, selling an estimated $15.5M.
  • Sector Gamma AS's ten largest holdings make up 68% of its $369M portfolio in Q3 2015.
  • Sector Gamma AS opened 2 new positions and closed 2 in Q3 2015.
  • Sector Gamma AS's portfolio value fell 5.7% quarter-over-quarter to $369M.

Based on Sector Gamma AS's 13F filing for Q3 2015, filed 16 Nov 2015.